Top Markets
Coin of the day
PCI Biotech Holding ASA PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCIB
Ранг среди акций #40013
PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is... PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is focused on pioneering and bringing to market innovative treatments for cancer. At the core of their operations is the proprietary photochemical internalization (PCI) technology platform. The company's development pipeline features several distinct therapeutic strategies: fimaCHEM, a novel approach to chemotherapeutic cancer treatment; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is currently in Phase I clinical studies; and fimaNAc, a delivery system for nucleic acid therapeutics, presently in its pre-clinical phase. Furthermore, they provide Amphinex, a photosensitizer known as fimaporfin. PCI Biotech actively participates in joint research endeavors with partners such as Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense.
Цена акции
$0.00733708
Последняя синхронизация: 2026-04-23
Рыночная капитализация
$273.87K
Изменение (1 день)
-39.13%
Изменение (1 год)
-94.83%
Страна
NO
Торговля PCI Biotech Holding ASA (PCIB)

Категория

Коэффициент P/S для PCI Biotech Holding ASA (PCIB)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций PCI Biotech Holding ASA, текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для PCI Biotech Holding ASA с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE